Mingli Peng

1.2k total citations
58 papers, 808 citations indexed

About

Mingli Peng is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Mingli Peng has authored 58 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 23 papers in Hepatology and 14 papers in Infectious Diseases. Recurrent topics in Mingli Peng's work include Hepatitis B Virus Studies (25 papers), Liver Disease Diagnosis and Treatment (21 papers) and Hepatitis C virus research (14 papers). Mingli Peng is often cited by papers focused on Hepatitis B Virus Studies (25 papers), Liver Disease Diagnosis and Treatment (21 papers) and Hepatitis C virus research (14 papers). Mingli Peng collaborates with scholars based in China, United States and United Kingdom. Mingli Peng's co-authors include Peng Hu, Hong Ren, Min Chen, Wenwei Yin, Hu Li, Hong Ren, Yuxuan Luo, Zhiwei Chen, Chunhua Zeng and Dachuan Cai and has published in prestigious journals such as Bioinformatics, PLoS ONE and Scientific Reports.

In The Last Decade

Mingli Peng

55 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingli Peng China 19 344 222 214 172 162 58 808
Melanie Werner Germany 14 262 0.8× 191 0.9× 196 0.9× 133 0.8× 123 0.8× 34 597
Chunwei Shi China 19 254 0.7× 92 0.4× 370 1.7× 248 1.4× 263 1.6× 37 950
Vahdat Poortahmasebi Iran 15 208 0.6× 150 0.7× 147 0.7× 80 0.5× 97 0.6× 57 574
Yuan Hu China 20 568 1.7× 274 1.2× 526 2.5× 150 0.9× 216 1.3× 67 1.3k
Joby Cole United Kingdom 14 166 0.5× 37 0.2× 321 1.5× 201 1.2× 146 0.9× 40 806
Mehmet Sami Serin Türkiye 16 275 0.8× 66 0.3× 308 1.4× 63 0.4× 140 0.9× 53 843
Fereshteh Jafari Iran 15 96 0.3× 173 0.8× 222 1.0× 180 1.0× 136 0.8× 26 1.0k
Imran Ahmad United States 15 196 0.6× 403 1.8× 345 1.6× 96 0.6× 339 2.1× 21 1.1k
Parvapan Bhattarakosol Thailand 15 294 0.9× 39 0.2× 175 0.8× 87 0.5× 147 0.9× 76 713
Pilar García–Peñarrubia Spain 19 184 0.5× 95 0.4× 334 1.6× 599 3.5× 104 0.6× 61 1.2k

Countries citing papers authored by Mingli Peng

Since Specialization
Citations

This map shows the geographic impact of Mingli Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingli Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingli Peng more than expected).

Fields of papers citing papers by Mingli Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingli Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingli Peng. The network helps show where Mingli Peng may publish in the future.

Co-authorship network of co-authors of Mingli Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Mingli Peng. A scholar is included among the top collaborators of Mingli Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingli Peng. Mingli Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chunrui, Hu Li, Zhiwei Chen, et al.. (2025). Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study. Virology Journal. 22(1). 36–36.
2.
Wu, Na, Zhiwei Chen, Wenhan Huang, et al.. (2024). Clinical and immunological features of COVID‐19 in patients with anti‐MDA5 dermatomyositis during the omicron wave in Chongqing, China. Journal of Medical Virology. 96(3). e29493–e29493. 1 indexed citations
3.
Chen, Zhiwei, Hu Li, Li Zhang, et al.. (2023). Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Chinese mainland and a phylogenetic analysis. Infectious Diseases of Poverty. 12(1). 66–66. 8 indexed citations
4.
Chen, Zhiwei, Xiaorong Peng, Hu Li, et al.. (2023). Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection. Frontiers in Cellular and Infection Microbiology. 13. 1201101–1201101. 1 indexed citations
5.
Xiao, Jing, et al.. (2023). GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARγ/CD36 pathway and altering the gut microbiota. European Journal of Pharmacology. 960. 176113–176113. 21 indexed citations
6.
Han, Shanshan, et al.. (2023). Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer. Frontiers in Public Health. 11. 1086872–1086872. 2 indexed citations
7.
Shen, Wei, Hui Tang, Mingli Peng, et al.. (2022). KMCP: accurate metagenomic profiling of both prokaryotic and viral populations by pseudo-mapping. Bioinformatics. 39(1). 28 indexed citations
8.
9.
Xiao, Jing, et al.. (2022). Dynamics of the gut-liver axis in rats with varying fibrosis severity. International Journal of Biological Sciences. 18(8). 3390–3404. 17 indexed citations
10.
11.
Deng, Yanhong, et al.. (2021). Curc-mPEG454, a PEGylated curcumin derivative, as a multi-target anti-fibrotic prodrug. International Immunopharmacology. 101(Pt A). 108166–108166. 10 indexed citations
12.
Chen, Zhiwei, Hu Li, Wei Shen, et al.. (2021). Potential Molecular Targets of Tenofovir Disoproxil Fumarate for Alleviating Chronic Liver Diseases via a Non-Antiviral Effect in a Normal Mouse Model. Frontiers in Molecular Biosciences. 8. 763150–763150. 4 indexed citations
13.
Xue, Wei, Kai Liu, Ke Qiu, et al.. (2019). A systematic review with meta-analysis: Is ribavirin necessary in sofosbuvir-based direct-acting antiviral therapies for patients with HCV recurrence after liver transplantation?. International Journal of Infectious Diseases. 83. 56–63. 3 indexed citations
14.
Pan, Zhaojun, Li Zhang, Wei Xue, et al.. (2019). Increased effector γδ T cells with enhanced cytokine production are associated with inflammatory abnormalities in severe hand, foot, and mouth disease. International Immunopharmacology. 73. 172–180. 5 indexed citations
15.
16.
Liu, Bin, Li Zhang, Hu Li, et al.. (2018). Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg. International Immunopharmacology. 62. 59–66. 23 indexed citations
17.
18.
Yin, Wenwei, Shiwen Tong, Qiongfang Zhang, et al.. (2016). Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Scientific Reports. 6(1). 26296–26296. 23 indexed citations
19.
Zeng, Chunhua, et al.. (2011). [The effects of curcumin derivative on experimental steatohepatitis].. PubMed. 19(6). 454–9. 10 indexed citations
20.
Xu, Hongmei, Mingli Peng, Yinghua Lan, et al.. (2005). A Quasi Species of the pre‐S/S Gene and Mutations of Enhancer II/Core Promoter/pre‐C in Mothers and Their Children Infected with Hepatitis B Virus via Mother‐to‐Infant Transmission. The Journal of Infectious Diseases. 193(1). 88–97. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melanie Werner Breakdown of academic impact, for papers by Chunwei Shi Breakdown of academic impact, for papers by Vahdat Poortahmasebi Breakdown of academic impact, for papers by Yuan Hu Breakdown of academic impact, for papers by Joby Cole Breakdown of academic impact, for papers by Mehmet Sami Serin Breakdown of academic impact, for papers by Fereshteh Jafari Breakdown of academic impact, for papers by Imran Ahmad Breakdown of academic impact, for papers by Parvapan Bhattarakosol Breakdown of academic impact, for papers by Pilar García–Peñarrubia
Rankless by CCL
2026